Alerts in the last 24 hours

No Personalised Alerts!

To see personalised alerts you need to be logged in.

Log In

Humana Inc Add to portfolio

INX:HUM, Dec 11, 04:52 UTC

Latest INX:HUM News

Filter your feed

Apply Filter

Friday, December 07


News

FY2018 EPS Estimates for Humana Inc Boosted by Analyst (NYSE:HUM) – Fairfield Current

HUM

Humana Inc (NYSE:HUM) – Research analysts at Leerink Swann increased their FY2018 earnings per share estimates for shares of Humana in a research note issued on Thursday, November 8th, according to Zacks Investment Research. Leerink Swann analyst A. Gupte now expects that the insurance provider will post earnings per share of $14.50 for the year, up from their prior estimate of $14.25. Leerink Swann also issued estimates for Humana’s Q1 2019 earnings at $4.36 EPS, Q2 2019 earnings at $4.85 EPS, Q3 2019 earnings at $5.50 EPS, Q4 2019 earnings at $3.55 EPS, FY2019 earnings at $18.25 EPS, FY2020 earnings at $20.50 EPS and FY2021 earnings at $23.00 EPS. Meag Munich Ergo Kapitalanlagegesellschaft MBH now owns 10,873 shares of the insurance provider’s stock valued at $3,256,000 after buying an additional 9,873 shares during the period.

Read Full Details

Topics:
  • Business
  • Financial

Tuesday, December 04


News

Humana Announces Key Strategic Leadership Appointment and Care Delivery Realignment

HUM

In the role of Chief Strategy and Corporate Development Officer, Agrawal will report directly to Humana President and CEO Bruce Broussard, and will serve as a member of Humana’s Management Team. Agrawal brings more than 20 years of experience in planning and implementing strategies to drive growth and performance improvement across publicly traded and privately held health care organizations. “His unique perspective will help Humana continue to advance its integrated care delivery market strategy, which revolves around the health plan member, with a particular focus on seniors living with chronic conditions.”. He also holds a master’s degree in molecular biophysics and a bachelor’s degree in molecular biophysics and biochemistry, both also from Yale. As Chief Strategy and Corporate Development Officer, Agrawal succeeds Christopher Hunter, who recently assumed leadership responsibility for the company’s Group, Specialty and Military lines of business.

Read Full Details

Topics:
  • Business
  • Health
  • Financial
  • Science
News

Humana Inc (HUM) Shares Bought by Bellevue Group AG – PressOracle

HUM

Massachusetts Financial Services Co. MA now owns 768,245 shares of the insurance provider’s stock worth $228,653,000 after purchasing an additional 26,303 shares in the last quarter. Finally, Royal Bank of Canada raised their target price on Humana from $318.00 to $349.00 and gave the company a “sector perform” rating in a research report on Thursday, November 8th. The stock has a market capitalization of $45.20 billion, a P/E ratio of 28.48, a PEG ratio of 1.56 and a beta of 0.99. During the same period in the previous year, the firm posted $3.39 EPS. As a group, analysts expect that Humana Inc will post 14.43 earnings per share for the current year.

Read Full Details

Topics:
  • Business
  • Financial

Monday, December 03


News

As Humana INC (HUM) Stock Value Rose, Columbus Hill Capital Management LP Increased Holding

HUM

121.65 million shares or 0.51% less from 122.28 million shares in 2018Q1 were reported. Lombard Odier Asset (Switzerland) Sa has 1.32% invested in Humana Inc. (NYSE:HUM) for 41,954 shares. State Street holds 0.14% in Humana Inc. (NYSE:HUM) or 5.53 million shares. Since June 4, 2018, it had 0 buys, and 10 insider sales for $33.24 million activity. More notable recent Humana Inc. (NYSE:HUM) news were published by: Bizjournals.com which released: “Humana execs to cash out millions in stock as shares jump to all-time high – Louisville Business First” on November 12, 2018, also Seekingalpha.com with their article: “Game Plan For The Week – Cramer’s Mad Money (11/2/18) – Seeking Alpha” published on November 05, 2018, Investorplace.com published: “CVS Health Chooses a Different Strategy in Walgreens Drug Store War – Investorplace.com” on November 27, 2018.

Read Full Details

Topics:
  • Business
  • Financial

Sunday, December 02


News

Humana (HUM) Releases FY 2018 Earnings Guidance – Marea Informative

HUM

The stock has a market cap of $45.31 billion, a PE ratio of 28.14, a PEG ratio of 1.57 and a beta of 1.03. During the same quarter in the previous year, the business earned $3.39 EPS. As a group, sell-side analysts forecast that Humana will post 14.43 EPS for the current year. Piper Jaffray Companies upped their price target on Humana from $355.00 to $380.00 and gave the stock an overweight rating in a report on Friday, August 24th. In other Humana news, insider Roy A. Beveridge sold 4,622 shares of the company’s stock in a transaction that occurred on Thursday, November 8th.

Read Full Details

Topics:
  • Business
  • Financial

Saturday, December 01


News

Humana Inc (HUM) to Post FY2018 Earnings of $14.42 Per Share, SunTrust Banks Forecasts – Fairfield Current

HUM STI

Humana Inc (NYSE:HUM) – Equities researchers at SunTrust Banks upped their FY2018 EPS estimates for Humana in a research note issued to investors on Tuesday, November 13th, according to Zacks Investment Research. SunTrust Banks also issued estimates for Humana’s Q4 2018 earnings at $2.50 EPS, Q1 2019 earnings at $4.04 EPS, Q2 2019 earnings at $4.66 EPS, Q3 2019 earnings at $5.26 EPS, Q4 2019 earnings at $3.34 EPS and FY2019 earnings at $17.30 EPS. Migdal Insurance & Financial Holdings Ltd. now owns 401 shares of the insurance provider’s stock worth $119,000 after purchasing an additional 388 shares in the last quarter. In other Humana news, insider Roy A. Beveridge sold 4,622 shares of the business’s stock in a transaction dated Thursday, November 8th.

Read Full Details

Topics:
  • Business
  • Financial

Friday, November 30


News

Consolidated Research: 2018 Summary Expectations for Resolute Forest Products, The Goldman Sachs Group, Humana, WEX, Parker-Hannifin, and Shoe Carnival — Fundamental Analysis, Key Performance Indications

HUM GS +1 more HUM GS PH

The new research reports from Market Source Research, available for free download at the links above, examine Resolute Forest Products Inc. (NYSE:RFP), The Goldman Sachs Group, Inc. (NYSE:GS), Humana Inc. (NYSE:HUM), WEX Inc. (NYSE:WEX), Parker-Hannifin Corporation (NYSE:PH), and Shoe Carnival, Inc. (NASDAQ:SCVL) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. The Goldman Sachs Group's Recent Financial Performance. For the three months ended September 30th, 2018 vs September 30th, 2017, The Goldman Sachs Group reported revenue of $8,646.00MM vs $8,326.00MM (up 3.84%) and analysts estimated basic earnings per share $6.35 vs $5.09 (up 24.75%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, The Goldman Sachs Group reported revenue of $32,073.00MM vs $30,608.00MM (up 4.79%) and analysts estimated basic earnings per share $9.12 vs $16.53 (down 44.83%). Market Source Research's team is comprised of financial professionals, many of which hold Chartered Financial Analyst® (CFA®) designations and FINRA® BrokerCheck® certifications. Whether identifying emerging trends, or discovering new opportunity, the team at Market Source Research is dedicated to providing accurate, informative, and objective content that’s ahead of the curve.

Read Full Details

Topics:
  • Business
  • Financial

Thursday, November 29


News

Humana to Gain from Share Buyback, Raise Membership Outlook

HUM

Shares of Humana Inc. HUM have gained by more than 6% in yesterday’s trading, after the company announced an accelerated share buyback program and revised 2019 Medicare Advantage (MA) membership outlook. Humana plans to repurchase its common stock worth $750 million through an accelerated stock repurchase agreement (the “ASR Agreement”) as part of the $3.0 billion share repurchase program, announced by the company on Dec 14, 2017.The ASR Agreement is consistent with the company’s previously anticipated capital deployment plans for the remainder of 2018 and 2019. This represents an increase of 100,000 members from its initial estimate, and 11% to 13% increase from the expected year ended Dec 31, 2018 membership level of approximately 3.07 million members.The upward revision was driven by better than expected retention of existing members during the Annual Enrollment Period (AEP) and higher-than-expected sales.For Group MA, net membership gains for 2019 are expected to increase approximately 30,000 members year over year. However, for Prescription Part D (PDP), the company now estimates a net membership decline of 750,000 to 800,000 members for the year ended Dec 31, 2019, compared to its initial estimate of a decline of approximately 500,000 members. Year to date, stock of the company has gained 33% compared with the industry’s growth of 26%.

Read Full Details

Topics:
  • Business
  • Financial

Wednesday, November 28


News

Humana (HUM) Issues FY18 Earnings Guidance – Marea Informative

HUM

Humana (NYSE:HUM) issued an update on its FY18 earnings guidance on Wednesday morning. The company has a market cap of $43.01 billion, a price-to-earnings ratio of 26.44, a PEG ratio of 1.49 and a beta of 1.03. During the same quarter in the previous year, the business posted $3.39 EPS. As a group, research analysts expect that Humana will post 14.43 EPS for the current fiscal year. Finally, Zacks Investment Research upgraded shares of Humana from a hold rating to a buy rating and set a $377.00 target price for the company in a report on Thursday, October 4th.

Read Full Details

Topics:
  • Business
  • Financial
News

Schroder Investment Management Group Acquires 36,725 Shares of Humana Inc (HUM) – Fairfield Current

HUM

Schroder Investment Management Group boosted its holdings in Humana Inc (NYSE:HUM) by 45.0% during the 3rd quarter, according to the company in its most recent filing with the SEC. During the same quarter last year, the business posted $3.39 EPS. As a group, equities analysts expect that Humana Inc will post 14.43 EPS for the current year. In other news, CEO Bruce D. Broussard sold 18,000 shares of the firm’s stock in a transaction that occurred on Monday, September 10th. Piper Jaffray Companies lifted their target price on shares of Humana from $355.00 to $380.00 and gave the stock an “overweight” rating in a research report on Friday, August 24th.

Read Full Details

Topics:
  • Business
  • Financial